Pharmacoepidemiology and Drug Safety

Papers
(The H4-Index of Pharmacoepidemiology and Drug Safety is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Statins and risk of diverticular disease: Nested case–control study56
Effect of 5‐HT2C receptor gene polymorphism (HTR2C−759C/T) on metabolic adverse effects in Thai psychiatric patients treated with risperidone49
Social media for early characterization of pandemic symptoms: A qualitative analysis of patient‐reported COVID‐19 experiences40
Issue Information34
Use of Causal Framework to Evaluate Effect of Abuse Deterrent Properties of Extended‐Release Oxycodone on Tampering in a Real‐World Settings30
INSIGHT: A Tool for Fit‐for‐Purpose Evaluation and Quality Assessment of Standardized Observational Data Sources for Real World Evidence on Medicine and Vaccine Safety28
Predictors of Potentially Inappropriate Stimulant Prescribing Among Adults27
Data Resource Profile: The Danish National Hospital Medicine Register23
Real‐World Evidence of Indapamide‐Induced Rhabdomyolysis: A Retrospective Analysis of Electronic Health Records23
Success of the German Cystic Fibrosis Registry23
Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis22
Incidence and outcomes of adverse drug reactions to first‐line anti‐tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study22
Validity of inpatient electronic health record‐based measures of oxygen‐related therapy in the United States: Lessons applicable for studying COVID‐19 endpoints22
21
20
Stability of individual dementia diagnoses in routine care: Implications for epidemiological studies20
Delayed pregnancy detection and return to fertility with extended levonorgestrel‐containing oral contraceptives: A real world setting cohort study19
Optimizing therapeutic decision‐making for off‐label medicines use: A scoping review and consensus recommendations for improving practice and research+19
Joint longitudinal trajectories of pain intensity and opioid prescription in veterans with back pain19
Control yourself: ISPE‐endorsed guidance in the application of self‐controlled study designs in pharmacoepidemiology19
0.065797090530396